Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

What Does a Fragile X Grey Zone Test Result Mean?

At a Glance

A Fragile X grey zone (intermediate) test result means you have 45 to 54 CGG repeats on the FMR1 gene. You do not have Fragile X Syndrome, you are not at risk for carrier-related health conditions, and the chance of passing the syndrome to your immediate children is essentially zero.

Getting test results back with unfamiliar terms like “intermediate” or “grey zone” can be incredibly stressful, especially when it concerns your family’s health. If your genetic test shows you are in the grey zone (also called the intermediate zone) for the FMR1 gene, it means you have between 45 and 54 CGG repeats in your DNA [1][2]. Most importantly: you do not have Fragile X Syndrome, and the chance of you passing a full Fragile X mutation to your immediate children is essentially zero [3][4].

To understand what this means, it helps to look at how the FMR1 gene is categorized based on the number of repeats:

  • Normal: 5 to 44 repeats
  • Grey Zone (Intermediate): 45 to 54 repeats [1]
  • Premutation (Carrier): 55 to 200 repeats [5]
  • Full Mutation: More than 200 repeats [6]

What This Means For Your Health

You do not have Fragile X Syndrome [7]. The symptoms of Fragile X Syndrome only occur when the number of repeats exceeds 200, which shuts down the gene and prevents it from making a crucial protein [6]. Because your repeat number is much lower, your gene still produces the required protein and functions like a “normal” gene for your day-to-day health.

If you have read about adult-onset conditions like Fragile X-Associated Primary Ovarian Insufficiency (FXPOI) (early menopause) or Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) (a neurological condition causing tremors), you can be reassured. These conditions are linked to the premutation range (55-200 repeats) [5][8]. Current medical consensus confirms that being in the grey zone is not a risk factor for FXTAS or FXPOI [9][10]. Your risk for these conditions is considered the same as the general public.

What This Means For Your Children

Parents in the grey zone often worry most about their children. The medical evidence is highly reassuring: there are no documented cases of a grey zone allele (45-54 repeats) expanding directly to a full mutation (over 200 repeats) in a single generation [3][4]. This means the risk of your immediate children being born with Fragile X Syndrome is effectively zero.

How you pass this gene down depends on your biological sex, because the FMR1 gene is located on the X chromosome:

  • If you are a biological father: You will pass the grey zone gene to all of your daughters, but none of your sons (sons inherit your Y chromosome).
  • If you are a biological mother: Each of your children (sons and daughters) has a 50% chance of inheriting the grey zone gene.

What This Means For Future Generations

While your immediate children will not have Fragile X Syndrome, the gene can sometimes be slightly unstable when passed down. Expansion—where the number of repeats increases—happens almost exclusively when the gene is passed down by a biological mother [3].

When passed down, the number of repeats can sometimes increase slightly, potentially moving into the premutation range (55 to 200 repeats) [3]. If a child inherits a premutation, they become a carrier. As a carrier, their future children (your grandchildren or great-grandchildren) might then face a risk of inheriting a full mutation [9].

The chance of the gene expanding largely depends on AGG interruptions [11][12]. These are tiny variations in the DNA sequence that act like genetic “speed bumps” or anchors, keeping the repeats stable [13][14]. While testing for AGG interruptions can tell us exactly how stable the gene is, clinical guidelines typically reserve this specific test for women who are already in the premutation range. It is not routinely recommended or necessary for individuals in the grey zone because the immediate risk of a full mutation in offspring is zero.

Next Steps to Consider

  • Request a copy of your exact lab report: Make sure you know your precise number of CGG repeats.
  • Consult a genetic counselor: A counselor can map out your family tree, explain inheritance patterns, and help you understand exactly what these results mean for your unique family structure.
  • Share results with your family: Let your parents and siblings know about your test results. Because this is genetic, your siblings may also carry an intermediate or premutation allele without knowing it, and this information could be valuable for their own family planning.

Common questions in this guide

What does a Fragile X grey zone result mean?
A grey zone or intermediate result means your DNA has between 45 and 54 CGG repeats on the FMR1 gene. This means you do not have Fragile X Syndrome, and the gene still produces the necessary proteins for normal daily health.
Can I pass Fragile X Syndrome to my children if I am in the grey zone?
The risk of passing a full Fragile X mutation to your immediate children is effectively zero. Medical evidence shows that a grey zone gene does not expand into a full mutation in a single generation.
Am I at risk for FXTAS or FXPOI with a grey zone result?
No, being in the grey zone is not a risk factor for adult-onset conditions like Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) or primary ovarian insufficiency (FXPOI). Your risk for these is the same as the general public.
Should my family members get genetic testing based on my result?
Yes, sharing your results with your parents and siblings is highly recommended. Because this is a genetic finding, your siblings may also carry an intermediate or premutation gene, which could be important for their own family planning.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my exact number of CGG repeats on my test?
  2. 2.Given that my result is in the grey zone, do I need to be monitored for any specific health conditions, or is my care exactly the same as the general population?
  3. 3.Should my siblings or other blood relatives be offered genetic testing based on my intermediate result?
  4. 4.Can you provide a referral to a genetic counselor to discuss how this might affect my extended family and future generations?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Population-based FMR1 carrier screening among reproductive women.

    Ain Q, Hwang YH, Yeung D, et al.

    Journal of assisted reproduction and genetics 2024; (41(11)):3237-3243 doi:10.1007/s10815-024-03242-2.

    PMID: 39320553
  2. 2

    [Fragile X syndrome and FMR1-dependent diseases - diagnostic scheme based on own experience .]

    Landowska A, Rzońca S, Bal J, Gos M

    Developmental period medicine 2018; (22(1)):22-32.

    PMID: 29641418
  3. 3

    Effect of AGG Interruptions on FMR1 Maternal Transmissions.

    Villate O, Ibarluzea N, Maortua H, et al.

    Frontiers in molecular biosciences 2020; (7()):135 doi:10.3389/fmolb.2020.00135.

    PMID: 32766278
  4. 4

    Challenges in prenatal screening and counselling for fragile X syndrome.

    Mak AS, Leung KY

    Hong Kong medical journal = Xianggang yi xue za zhi 2017; (23(2)):108-9 doi:10.12809/hkmj175064.

    PMID: 28387201
  5. 5

    Mild Neurological Signs in FMR1 Premutation Women in an Unselected Community-Based Cohort.

    Mailick MR, Hong J, Movaghar A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2021; (36(10)):2378-2386 doi:10.1002/mds.28683.

    PMID: 34117786
  6. 6

    Epigenetics of fragile X syndrome and fragile X-related disorders.

    Kraan CM, Godler DE, Amor DJ

    Developmental medicine and child neurology 2019; (61(2)):121-127 doi:10.1111/dmcn.13985.

    PMID: 30084485
  7. 7

    Clinical, Genetic and Molecular Divergences Between Full Mutation and Premutation in Fragile X Syndrome: A Systematic Review.

    Souski H, Benmakhlouf Y, Mechita MB

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2025; (85(6)):e70054 doi:10.1002/jdn.70054.

    PMID: 40985503
  8. 8

    Fragile X syndrome: clinical presentation, pathology and treatment.

    Salcedo-Arellano MJ, Hagerman RJ, Martínez-Cerdeño V

    Gaceta medica de Mexico 2020; (156(1)):60-66 doi:10.24875/GMM.19005275.

    PMID: 32026885
  9. 9

    Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome.

    Salcedo-Arellano MJ, Wolf-Ochoa MW, Hong T, et al.

    Movement disorders clinical practice 2020; (7(4)):413-418 doi:10.1002/mdc3.12942.

    PMID: 32373658
  10. 10

    Women with Fragile X-associated Tremor/Ataxia Syndrome.

    Schneider A, Summers S, Tassone F, et al.

    Movement disorders clinical practice 2020; (7(8)):910-919 doi:10.1002/mdc3.13084.

    PMID: 33163562
  11. 11

    Ethnicity has a multiplex impact upon the risk of a full mutation expansion among female heterozygotes for FMR1 premutation.

    Domniz N, Levavi LR, Berkenstadt M, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(6)):1023-1027 doi:10.1038/s41436-020-01089-3.

    PMID: 33473206
  12. 12

    Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation Carriers.

    Domniz N, Ries-Levavi L, Cohen Y, et al.

    Frontiers in genetics 2018; (9()):606 doi:10.3389/fgene.2018.00606.

    PMID: 30619448
  13. 13

    Development of Genetic Testing for Fragile X Syndrome and Associated Disorders, and Estimates of the Prevalence of FMR1 Expansion Mutations.

    Macpherson JN, Murray A

    Genes 2016; (7(12)).

    PMID: 27916885
  14. 14

    Towards a Better Molecular Diagnosis of FMR1-Related Disorders-A Multiyear Experience from a Reference Lab.

    Rzońca SO, Gos M, Szopa D, et al.

    Genes 2016; (7(9)).

    PMID: 27598204

This page is for informational purposes only and does not replace professional medical advice. Always consult a genetic counselor or your healthcare provider to interpret your specific genetic test results.

Get notified when new evidence is published on Fragile X syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.